Mouse hepatitis virus strain JHM infects a human hepatocellular carcinoma cell line

Virology

Volumn 264, Issue 2, 1999, Pages 398-409

  Koetters, Peter J ^a   Hassanieh, Loubna ^a   Stohlman, Stephen A ^a   Gallagher, Thomas ^b   Lai, Michael M C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; CORONAVIRUS; DEMYELINATION; HEPATITIS VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR BINDING; RODENT; T LYMPHOCYTE;

EID: 0033604580     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9984     Document Type: Article

References (63)

1. Asanaka M., Lai M. M. C. Cell fusion studies identified multiple cellular factors involved in mouse hepatitis virus entry. Virology. 197:1993;732-741.
2. Baric R. S., Sullivan E., Hensley L., Yount B., Chen W. Persistent infection promotes cross-species transmissibility of mouse hepatitis virus. J. Virol. 73:1999;638-649.
3. Burks J. S., DeVald B. L., Jankovsky L. D., Gerdes J. C. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science. 209:1980;933-934.
4. Cabirac G. F., Soike K. F., Zhang J. Y., Hoel K., Butunoi C., Cai G. Y., Johnson S., Murray R. S. Entry of coronavirus into primate CNS following peripheral infection. Microb. Pathog. 16:1994;349-357.
5. Chen D. S., Asanaka M., Chen F. S., Shively J. E., Lai M. M. C. Human carcinoembryonic antigen and biliary glycoprotein can serve as mouse hepatitis virus receptors. J. Virol. 71:1997;1688-1691.
6. Chen D. S., Asanaka M., Yokomori K., Wang F., Hwang S. B., Li H. P., Lai M. M. A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc. Natl. Acad. Sci. USA. 92:1995;12095-12099.
7. Chen W., Yount B., Hensley L., Baric R. S. Receptor homologue scanning functions in the maintenance of MHV-A59 persistence in vitro. Adv. Exp. Med. Biol. 440:1998;743-750.
8. Compton S. R., Barthold S. W., Smith A. L. The cellular and molecular pathogenesis of coronaviruses [published erratum appears in Lab. Anim. Sci., 1993, 43, 203]. Lab. Anim. Sci. 43:1993;15-28.
9. Dalgleish A. G. Viruses and multiple sclerosis. Acta. Neurol. Scand. Suppl. 169:1997;8-15.
10. Deregt D., Gifford G. A., Ijaz M. K., Watts T. C., Gilchrist J. E., Haines D. M., Babiuk L. A. Monoclonal antibodies to bovine coronavirus glycoproteins E2 and E3: Demonstration of in vivo virus-neutralizing activity. J. Gen. Virol. 70:1989;993-998.
11. Dveksler G. S., Dieffenbach C. W., Cardellichio C. B., McCuaig K., Pensiero M. N., Jiang G. S., Beauchemin N., Holmes K. V. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol. 67:1993;1-8.
12. Dveksler G. S., Pensiero M. N., Cardellichio C. B., Williams R. K., Jiang G. S., Holmes K. V., Dieffenbach C. W. Cloning of the mouse hepatitis virus (MHV) receptor: Expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:1991;6881-6891.
13. Fleming J. O., Stohlman S. A., Harmon R. C., Lai M. M. C., Frelinger J. A., Weiner L. P. Antigenic relationships of murine coronaviruses: Analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology. 131:1983;296-307.
14. Fleming J. O., Trousdale M. D., Bradbury J., Stohlman S. A., Weiner L. P. Experimental demyelination induced by coronavirus JHM (MHV-4): Molecular identification of a viral determinant of paralytic disease. Microb. Pathog. 3:1987;9-20.
15. Fleury H. J. A., Sheppard R. D., Bornstein M. B., Raine C. S. Further ultrastructural observations of virus morphogenesis and myelin pathology in JHM virus encephalomyelitis. Neuropathol. Appl. Neurobiol. 6:1980;165-179.
16. Gallagher T. M. Murine coronavirus membrane fusion is blocked by modification of thiols buried within the spike protein. J. Virol. 70:1996;4683-4690.
17. Gallagher T. M. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J. Virol. 71:1997;3129-3137.
18. Geraghty R. J., Krummenacher C., Cohen G. H., Eisenberg R. J., Spear P. G. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science. 280:1998;1618-1620.
19. Gerdes J. C., Klein I., DeVald B. L., Burks J. S. Coronavirus isolates SK and SD from multiple sclerosis patients are serologically related to murine coronaviruses A59 and JHM and human coronavirus OC43, but not to human coronavirus 229E. J. Virol. 38:1981;231-238.
20. Goto N., Hirano N., Aiuchi M., Hayashi T., Fujiwara K. Nasoencephalopathy of mice infected intranasally with a mouse hepatitis virus, JHM strain. Jpn. J. Exp. Med. 47:1977;59-70.
21. Hensley L. E., Baric R. S. Human biliary glycoproteins function as receptors for interspecies transfer of mouse hepatitis virus. Adv. Exp. Med. Biol. 440:1998;43-52.
22. Hensley L. E., Holmes K. V., Beauchemin N., Baric R. S. Virus-receptor interactions and interspecies transfer of a mouse hepatitis virus. Adv. Exp. Med. Biol. 440:1998;33-41.
23. Herndon R. M., Griffin D. E., McCormick U., Weiner L. P. Mouse hepatitis virus-induced recurrent demyelination: A preliminary report. Arch. Neurol. 32:1975;32-35.
24. Hierholzer J. C., Broderson J. R., Murphy F. A. New strain of mouse hepatitis virus as the cause of lethal enteritis in infant mice. Infect. Immun. 24:1979;508-522.
25. Hirano N., Fujiwara K., Hino S., Matumoto M. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Gesamte Virusforsch. 44:1974;298-302.
26. Johnson R. T. The virology of demyelinating diseases. Ann. Neurol. 36:1994;S54-S60.
27. Kubo H., Takase-Yoden S., Taguchi F. Neutralization and fusion inhibition activities of monoclonal antibodies specific for the S1 subunit of the spike protein of neurovirulent murine coronavirus JHMV c1-2 variant. J. Gen. Virol. 74:1993;1421-1425.
28. Kubo H., Yamada Y. K., Taguchi F. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J. Virol. 68:1994;5403-5410.
29. Kurtzke J. F. Epidemiologic evidence for multiple sclerosis as an infection [published erratum appears in Clin. Microbiol. Rev., 1994, 7, 141]. Clin. Microbiol. Rev. 6:1993;382-427.
30. Lai M. M. C. RNA recombination in animal and plant viruses. Microbiol. Rev. 56:1992;61-79.
31. Lai M. M. C., Brayton P. R., Armen R. C., Patton C. D., Pugh C., Stohlman S. A. Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J. Virol. 39:1981;823-834.
32. Lai M. M. C., Stohlman S. A. Comparative analysis of RNA genomes of mouse hepatitis viruses. J. Virol. 38:1981;661-670.
33. Lane T. E., Buchmeier M. J. Murine coronavirus infection: A paradigm for virus-induced demyelinating disease [see comments]. Trends Microbiol. 5:1997;9-14.
34. Makino S., Taguchi F., Hirano N., Fujiwara K. Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology. 139:1984;138-151.
35. Moore J. P., Trkola A., Dragic T. Co-receptors for HIV-1 entry [see comments]. Curr. Opin. Immunol. 9:1997;551-562.
36. Morris V. L., Tieszer C., Mackinnon J., Percy D. Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease. Virology. 169:1989;127-136.
37. Murray R. S., Brown B., Brian D., Cabirac G. F. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann. Neurol. 31:1992a;525-533.
38. Murray R. S., Cai G. Y., Hoel K., Johnson S., Cabirac G. F. Coronaviruses and multiple sclerosis. Adv. Exp. Med. Biol. 342:1993;353-357.
39. Murray R. S., Cai G. Y., Hoel K., Zhang J. Y., Soike K. F., Cabirac G. F. Coronavirus infects and causes demyelination in primate central nervous system. Virology. 188:1992b;274-284.
40. Murray R. S., Cai G. Y., Soike K. F., Cabirac G. F. Further observations on coronavirus infection of primate CNS. J. Neurovirol. 3:1997;71-75.
41. Murray R. S., MacMillan B., Cabirac G. F., Burks J. S. Detection of coronavirus RNA in CNS tissue of multiple sclerosis and control patients. Adv. Exp. Med. Biol. 276:1990;505-510.
42. Nagashima K., Wege H., ter Meulen V. Early and late CNS-effects of corona virus infection in rats. Adv. Exp. Med. Biol. 100:1978;395-409.
43. Nakabayashi H., Taketa K., Miyano K., Yamane T., Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 42:1982;3858-3863.
44. Poser C. M. The epidemiology of multiple sclerosis: A general overview. Ann. Neurol. 36:1994;S180-S193.
45. Powell H. C., Lampert P. W. Oligodendrocytes and their myelin-plasma membrane connections in JHM mouse hepatitis virus encephalomyelitis. Lab. Invest. 33:1975;440-445.
46. Schickli J. H., Zelus B. D., Wentworth D. E., Sawicki S. G., Holmes K. V. The murine coronavirus mouse hepatitis virus strain A59 from persistently infected murine cells exhibits an extended host range. J. Virol. 71:1997;9499-9507.
47. Selinka H. C., Huber M., Pasch A., Klingel K., Aepinus C., Kandolf R. Coxsackie B virus and its interaction with permissive host cells. Clin. Diagn. Virol. 9:1998;115-123.
48. Smith G. L., Vanderplasschen A. Extracellular enveloped vaccinia virus: Entry, egress, and evasion. Adv. Exp. Med. Biol. 440:1998;395-414.
49. Stohlman S. A., Brayton P. R., Fleming J. O., Weiner L. P., Lai M. M. C. Murine coronaviruses: Isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J. Gen. Virol. 63:1982;265-275.
50. Tanaka R., Iwasaki Y., Koprowski H. Intracisternal virus-like particles in brain of a multiple sclerosis patient. J. Neurol. Sci. 28:1976;121-126.
51. Thoulouze M. I., Lafage M., Schachner M., Hartmann U., Cremer H., Lafon M. The neural cell adhesion molecule is a receptor for rabies virus. J. Virol. 72:1998;7181-7190.
52. Wang F. I., Fleming J. O., Lai M. M. C. Sequence analysis of the spike protein gene of murine coronavirus variants: Study of genetic sites affecting neuropathogenicity. Virology. 186:1992;742-749.
53. Wang J., Chou C. H., Blankson J., Satoh M., Knuth M. W., Eisenberg R. A., Pisetsky D. S., Reeves W. H. Murine monoclonal antibodies specific for conserved and non-conserved antigenic determinants of the human and murine Ku autoantigens. Mol. Biol. Rep. 18:1993;15-28.
54. Watanabe R., Wege H., ter Meulen V. Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature. 305:1983;150-153.
55. Weiss S. R. Coronaviruses SD and SK share extensive nucleotide homology with murine coronavirus MHV-A59, more than that shared between human and murine coronaviruses. Virology. 126:1983;669-677.
56. Williams R. K., Jiang G. S., Snyder S. W., Frana M. F., Holmes K. V. Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice. J. Virol. 64:1990;3817-3823.
57. Yamamoto T., Suda M., Moriwaki Y., Takahashi S., Higashino K. Novel apoprotein A-I-containing lipoprotein produced by a human hepatoma-derived cell line HuH-7. Biochim. Biophys. Acta. 1047:1990;49-56.
58. Yokomori K., Asanaka M., Stohlman S. A., Lai M. M. C. A spike protein-dependent cellular factor other than the viral receptor is required for mouse hepatitis virus entry. Virology. 196:1993;45-56.
59. Yokomori K., Asanaka M., Stohlman S. A., Makino S., Shubin R. A., Gilmore W., Weiner L. P., Wang F. I., Lai M. M. C. Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression [see comments]. J. Neurovirol. 1:1995;330-339.
60. Yokomori K., Lai M. M. C. Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J. Virol. 66:1992;6194-6199.
61. Yokomori K., Lai M. M. C. Mouse hepatitis virus infection utilizes more than one receptor and requires an additional cellular factor. Adv. Exp. Med. Biol. 342:1993;273-277.
62. Yokomori K., Lai M. M. C. Mouse hepatitis virus receptors: More than a single carcinoembryonic antigen. Arch. Virol. Suppl. 9:1994;461-471.
63. Zhang X., Hinton D. R., Park S., Parra B., Liao C. L., Lai M. M. C., Stohlman S. A. Expression of hemagglutinin/esterase by a mouse hepatitis virus coronavirus defective-interfering RNA alters viral pathogenesis. Virology. 242:1998;170-183.